Table 1.
Percentage of prescribed drug groups for men and women from 2001 to 2017
| Total % (n = 1044) | Men % (n = 329) | Women % (n = 715) | χ2(1, n = 1044) | p | |
|---|---|---|---|---|---|
| Any medication | 94.0% (981) | 96.7% (318) | 92.7% (663) | 6.14 | 0.01* |
| Any psychotropics | 89.9% (939) | 91.8% (302) | 89.1% (637) | 1.82 | 0.18 |
| Antidepressant drugs | 72.0% (752) | 71.7% (236) | 72.2% (516) | 0.02 | 0.88 |
| SSRI | 32.5% (339) | 30.7% (101) | 33.3% (238) | 0.69 | 0.41 |
| SSNRI | 19.4% (203) | 20.4% (67) | 19.0% (136) | 0.26 | 0.61 |
| NaSSA | 15.2% (159) | 19.1% (63) | 13.4% (96) | 5.72 | 0.02* |
| TCA | 14.2% (148) | 10.6% (35) | 15.8% (113) | 4.94 | 0.03* |
| “Other antidepressants” | 11.1% (116) | 9.4% (31) | 11.9% (85) | 1.39 | 0.24 |
| Antipsychotic drugs | 58.4% (610) | 59.3% (195) | 58.0% (415) | 0.14 | 0.71 |
| SGA | 44.2% (461) | 45.9% (151) | 43.4% (310) | 0.59 | 0.44 |
| Low-potency FGA | 22.9% (239) | 20.1% (66) | 24.2% (173) | 2.18 | 0.14 |
| High-potency FGA | 5.2% (54) | 5.8% (19) | 4.9% (35) | 0.36 | 0.55 |
| Tranquilizing drugs | 29.3% (306) | 28.6% (94) | 29.7% (212) | 0.13 | 0.72 |
| Benzodiazepines | 26.9% (281) | 26.4% (87) | 27.1% (194) | 0.05 | 0.82 |
| Tricyclic tranquilizers | 1.3% (15) | 1.2% (4) | 1.5% (11) | 0.17 | 0.68 |
| Plant-based tranquilizers | 0.7% (7) | 0.9% (3) | 0.6% (4) | 0.42 | 0.52 |
| Hypnotic drugs | 12.3% (128) | 11.6% (38) | 12.6% (90) | 0.23 | 0.64 |
| Benzodiazepine analogues | 8.9% (93) | 9.1% (30) | 8.8% (63) | 0.03 | 0.87 |
| Benzodiazepines | 1.9% (20) | 1.8% (6) | 2.0% (14) | 0.02 | 0.88 |
| Plant-based hypnotics | 1.1% (12) | 0.9% (3) | 1.3% (9) | 0.24 | 0.63 |
| Antiepileptic drugs | 18.4% (192) | 16.1% (53) | 19.4% (139) | 1.67 | 0.20 |
| Lithium | 2.4% (25) | 0.6% (2) | 3.2% (23) | 6.56 | 0.01* |
| Antiparkinson drugs | 2.9% (30) | 2.4% (8) | 3.1% (22) | 0.34 | 0.56 |
| Nootropics | 0.5% (5) | 0.9% (3) | 0.3% (2) | 1.89 | 0.17 |
| Other psychotropics | 1.6% (17) | 2.1% (7) | 1.4% (10) | 0.75 | 0.39 |
SSRI selective serotonin reuptake inhibitor, SSNRI selective serotonin noradrenaline reuptake inhibitors, NaSSA noradrenergic and specific serotonergic antidepressants, TCA tricyclic antidepressants, Other antidepressants: trazodone n = 71, agomelatine n = 31, bupropion n = 14, reboxetine n = 3; SGA second-generation antipsychotics, FGA first-generation antipsychotics
*p < 0.05, reported p values are not corrected for multiple comparisons